Ancora Advisors, LLC My Md Pharmaceuticals, Inc. Transaction History

Ancora Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$3.34 - $6.05 $9,018 - $16,335	2,700 New	2,700 $13,000
Q1 2022 May 13, 2022	SELL	$3.34 - $6.05 $9,018 - $16,335	-2,700 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.39 - $6.98 $9,153 - $18,846	2,700 New	2,700 $17,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.